FiercePharma(@FiercePharma):In a stabilizing move, the Department of Health and Human Services has tapped Michael Davis, M.D., Ph.D., and Karim Mikhail—who’ve been serving as acting directors of the Centers for Drugs Evaluation and Research (CDER) and the Centers for Biologics Evaluation and Research (CBER), respectively—to occupy their posts on a permanent basis.

FiercePharma

@FiercePharma

Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.

加入 December 2008

466 正在關注 100.8K 粉絲

FiercePharma@FiercePharma

2026.09.09 15:34

In a stabilizing move, the Department of Health and Human Services has tapped Michael Davis, M.D., Ph.D., and Karim Mikhail—who’ve been serving as acting directors of the Centers for Drugs Evaluation and Research (CDER) and the Centers for Biologics Evaluation and Research (CBER), respectively—to occupy their posts on a permanent basis.